LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

The post LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”